| Primary |
| Hypertension |
55.3% |
| Product Used For Unknown Indication |
19.7% |
| Cardiovascular Disorder |
7.9% |
| Immunosuppression |
2.6% |
| Hypertension |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Blood Pressure |
1.3% |
| Breast Cancer |
1.3% |
| Diabetes Mellitus |
1.3% |
| Drug Withdrawal Syndrome |
1.3% |
| Oedema |
1.3% |
| Prophylaxis |
1.3% |
| Proteinuria |
1.3% |
| Renal Disorder |
1.3% |
| Supplementation Therapy |
1.3% |
|
| Swollen Tongue |
10.3% |
| Anaphylactic Reaction |
6.9% |
| Angioedema |
6.9% |
| Product Quality Issue |
6.9% |
| Renal Failure Chronic |
6.9% |
| Sensation Of Heaviness |
6.9% |
| Skin Lesion |
6.9% |
| Stress |
6.9% |
| Anxiety |
3.4% |
| Arrhythmia |
3.4% |
| Bronchitis |
3.4% |
| Completed Suicide |
3.4% |
| Coronary Artery Disease |
3.4% |
| Diabetes Mellitus |
3.4% |
| Face Oedema |
3.4% |
| Hyperkalaemia |
3.4% |
| Insomnia |
3.4% |
| Laryngeal Oedema |
3.4% |
| Lip Swelling |
3.4% |
| Middle Insomnia |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
23.0% |
| Hypertension |
19.7% |
| Sepsis |
11.5% |
| Hypotension |
6.6% |
| Tremor |
4.9% |
| Blood Cholesterol Increased |
3.3% |
| Cardiac Failure |
3.3% |
| Crohn's Disease |
3.3% |
| Pain |
3.3% |
| Peritoneal Dialysis |
3.3% |
| Suicide Attempt |
3.3% |
| Anxiety |
1.6% |
| Atrial Fibrillation |
1.6% |
| Back Pain |
1.6% |
| Blood Pressure |
1.6% |
| Blood Triglycerides Increased |
1.6% |
| Cardiovascular Disorder |
1.6% |
| Depression |
1.6% |
| Diabetic Nephropathy |
1.6% |
| High Cholesterol |
1.6% |
|
| Completed Suicide |
11.1% |
| Hypotension |
7.4% |
| Myalgia |
7.4% |
| Swollen Tongue |
7.4% |
| Toxic Epidermal Necrolysis |
7.4% |
| Vomiting |
7.4% |
| Abdominal Discomfort |
3.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.7% |
| Head Injury |
3.7% |
| Hyperkalaemia |
3.7% |
| Hypersensitivity |
3.7% |
| Intentional Overdose |
3.7% |
| Nightmare |
3.7% |
| Oropharyngeal Pain |
3.7% |
| Pain |
3.7% |
| Palpitations |
3.7% |
| Renal Failure Acute |
3.7% |
| Renal Impairment |
3.7% |
| Shock |
3.7% |
| Vasodilatation |
3.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.6% |
| Hypertension |
20.8% |
| Diabetes Mellitus |
4.6% |
| Blood Cholesterol Increased |
4.4% |
| Pain |
4.0% |
| Depression |
3.2% |
| Blood Pressure |
2.5% |
| Rheumatoid Arthritis |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Anxiety |
2.1% |
| Hepatitis C |
2.1% |
| Blood Pressure Abnormal |
1.7% |
| Atrial Fibrillation |
1.6% |
| Arthritis |
1.5% |
| Smoking Cessation Therapy |
1.5% |
| Hormone Replacement Therapy |
1.5% |
| Fibromyalgia |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Cardiac Disorder |
1.4% |
|
| Weight Decreased |
10.5% |
| Drug Ineffective |
8.6% |
| Vomiting |
6.8% |
| Pain |
6.4% |
| Pain In Extremity |
6.4% |
| Myocardial Infarction |
6.0% |
| Nausea |
6.0% |
| Weight Increased |
6.0% |
| Death |
5.3% |
| Rash |
4.9% |
| Wrong Technique In Drug Usage Process |
4.5% |
| Fatigue |
3.8% |
| Headache |
3.8% |
| Blood Pressure Increased |
3.0% |
| Diarrhoea |
3.0% |
| Feeling Abnormal |
3.0% |
| Injection Site Pain |
3.0% |
| Pneumonia |
3.0% |
| Renal Failure Acute |
3.0% |
| Somnolence |
3.0% |
|
